Increased liver steatosis in anabolic-androgenic steroid users: more evidence towards toxicant-associated fatty liver disease development

Liver Int. 2011 Sep;31(8):1240-1. doi: 10.1111/j.1478-3231.2011.02552.x. Epub 2011 May 26.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anabolic Agents / adverse effects*
  • Anabolic Agents / blood
  • Androgens / adverse effects*
  • Androgens / blood
  • Fatty Liver / blood
  • Fatty Liver / chemically induced*
  • Fatty Liver / pathology
  • Humans
  • Liver / drug effects*
  • Liver / pathology
  • Male
  • Non-alcoholic Fatty Liver Disease
  • Risk Assessment
  • Risk Factors
  • Time Factors

Substances

  • Anabolic Agents
  • Androgens